137 related articles for article (PubMed ID: 35466538)
1. Analysis of illicit drugs in purchased and seized electronic cigarette liquids from the United Kingdom 2014-2021.
Frinculescu A; Coombes G; Shine T; Ramsey J; Johnston A; Couchman L
Drug Test Anal; 2023 Oct; 15(10):1058-1066. PubMed ID: 35466538
[TBL] [Abstract][Full Text] [Related]
2. Cannabidiol and tetrahydrocannabinol concentrations in commercially available CBD E-liquids in Switzerland.
Grafinger KE; Krönert S; Broillet A; Weinmann W
Forensic Sci Int; 2020 May; 310():110261. PubMed ID: 32229319
[TBL] [Abstract][Full Text] [Related]
3. The analysis of cannabinoids in e-cigarette liquids using LC-HRAM-MS and LC-UV.
Barhdadi S; Courselle P; Deconinck E; Vanhee C
J Pharm Biomed Anal; 2023 Jun; 230():115394. PubMed ID: 37062207
[TBL] [Abstract][Full Text] [Related]
4. Absence of Relevant Thermal Conversion of Cannabidiol to Tetrahydrocannabinol in E-Cigarette Vapor and Low-Tetrahydrocannabinol Cannabis Smoke.
Hindelang P; Scharinger A; Golombek P; Laible M; Tamosaite S; Walch SG; Lachenmeier DW
Cannabis Cannabinoid Res; 2022 Oct; 7(5):616-620. PubMed ID: 36169637
[No Abstract] [Full Text] [Related]
5. Detection and quantitation of synthetic cannabinoid receptor agonists in infused papers from prisons in a constantly evolving illicit market.
Norman C; Walker G; McKirdy B; McDonald C; Fletcher D; Antonides LH; Sutcliffe OB; Nic Daéid N; McKenzie C
Drug Test Anal; 2020 Apr; 12(4):538-554. PubMed ID: 31944624
[TBL] [Abstract][Full Text] [Related]
6. Using the BMD Approach to Derive Acceptable Daily Intakes of Cannabidiol (CBD) and Tetrahydrocannabinol (THC) Relevant to Electronic Cigarette Liquids.
Hindelang P; Scharinger A; Richling E; Walch SG; Lachenmeier DW
Front Biosci (Landmark Ed); 2022 Jul; 27(8):228. PubMed ID: 36042166
[TBL] [Abstract][Full Text] [Related]
7. THC and CBD concentrations in blood, oral fluid and urine following a single and repeated administration of "light cannabis".
Pacifici R; Pichini S; Pellegrini M; Rotolo MC; Giorgetti R; Tagliabracci A; Busardò FP; Huestis MA
Clin Chem Lab Med; 2020 Apr; 58(5):682-689. PubMed ID: 30956228
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoid Content and Label Accuracy of Hemp-Derived Topical Products Available Online and at National Retail Stores.
Spindle TR; Sholler DJ; Cone EJ; Murphy TP; ElSohly M; Winecker RE; Flegel RR; Bonn-Miller MO; Vandrey R
JAMA Netw Open; 2022 Jul; 5(7):e2223019. PubMed ID: 35857320
[TBL] [Abstract][Full Text] [Related]
9. Combination of UV and MS/MS detection for the LC analysis of cannabidiol-rich products.
Nemeškalová A; Hájková K; Mikulů L; Sýkora D; Kuchař M
Talanta; 2020 Nov; 219():121250. PubMed ID: 32887141
[TBL] [Abstract][Full Text] [Related]
10. Detection of anabolic-androgenic steroids in e-cigarettes seized from prisons: A case study.
Harries RL; Norman C; Reid R; Nic Daéid N; Nisbet LA
Forensic Sci Int; 2024 Mar; 356():111965. PubMed ID: 38359752
[TBL] [Abstract][Full Text] [Related]
11. Content versus Label Claims in Cannabidiol (CBD)-Containing Products Obtained from Commercial Outlets in the State of Mississippi.
Gurley BJ; Murphy TP; Gul W; Walker LA; ElSohly M
J Diet Suppl; 2020; 17(5):599-607. PubMed ID: 32431186
[TBL] [Abstract][Full Text] [Related]
12. Potency of Δ
Potter DJ; Hammond K; Tuffnell S; Walker C; Di Forti M
Drug Test Anal; 2018 Apr; 10(4):628-635. PubMed ID: 29441730
[TBL] [Abstract][Full Text] [Related]
13. Shape matters: The application of activity-based in vitro bioassays and chiral profiling to the pharmacological evaluation of synthetic cannabinoid receptor agonists in drug-infused papers seized in prisons.
Antonides LH; Cannaert A; Norman C; NicDáeid N; Sutcliffe OB; Stove CP; McKenzie C
Drug Test Anal; 2021 Mar; 13(3):628-643. PubMed ID: 33161649
[TBL] [Abstract][Full Text] [Related]
14. An assessment of qualitative and quantitative cannabinoids analysis in selected commercially available cannabis oils in Argentina.
Fernández N; Cappello MG; Quiroga PN
Forensic Sci Int; 2023 Aug; 349():111762. PubMed ID: 37392612
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoids Tetrahydrocannabinol, Cannabinol, Cannabidiol, Tetrahydrocannabivarin and 11-nor-9-carboxy-∆9-THC in Hair.
Hill VA; Schaffer MI; Paulsen RB; Stowe GN
J Anal Toxicol; 2022 May; 46(5):487-493. PubMed ID: 34153110
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoids in Oral Fluid: Limiting Potential Sources of Cannabidiol Conversion to Δ9- and Δ8-Tetrahydrocannabinol.
Coulter C; Wagner JR
J Anal Toxicol; 2021 Sep; 45(8):807-812. PubMed ID: 34137890
[TBL] [Abstract][Full Text] [Related]
17. Cannabidiol (CBD) product contamination: Quantitative analysis of Δ
Johnson E; Kilgore M; Babalonis S
Drug Alcohol Depend; 2022 Aug; 237():109522. PubMed ID: 35690015
[TBL] [Abstract][Full Text] [Related]
18. CBD, a precursor of THC in e-cigarettes.
Czégény Z; Nagy G; Babinszki B; Bajtel Á; Sebestyén Z; Kiss T; Csupor-Löffler B; Tóth B; Csupor D
Sci Rep; 2021 Apr; 11(1):8951. PubMed ID: 33903673
[TBL] [Abstract][Full Text] [Related]
19. Large-scale evaluation of ion mobility spectrometry for the rapid detection of synthetic cannabinoid receptor agonists in infused papers in prisons.
Norman C; McKirdy B; Walker G; Dugard P; NicDaéid N; McKenzie C
Drug Test Anal; 2021 Mar; 13(3):644-663. PubMed ID: 33058556
[TBL] [Abstract][Full Text] [Related]
20. A validated method for the simultaneous quantification of cannabidiol, Δ
Kevin RC; Vogel R; Doohan P; Berger M; Amminger GP; McGregor IS
Drug Test Anal; 2021 Mar; 13(3):614-627. PubMed ID: 33095968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
